"A Test of Our Character as a Nation": President Obama on What We Need in the Fight Against Ebola

President Obama visited the Naitonal Institutes of Health (NIH) today to visit the team of scientists who recently made significant progress in developing an Ebola vaccine. "No potential Ebola vaccine has ever made it this far," he noted. 

Indeed, the United States is taking the lead in the world's response to Ebola -- in treating, containing, and preventing the spread of this devastating outbreak. As the President said, "Part of American leadership in the world -- one of the things that has always marked us as exceptional -- is our leadership in science and our leadership in research."

Related Topics: Ebola, Maryland

The White House

Office of the Press Secretary

Press Briefing by the Press Secretary Josh Earnest, 12/2/14

James S. Brady Press Briefing Room 
 
1:05 P.M. EST
 
MR. EARNEST:  Good afternoon, everybody.  Very festive mood in the briefing room today.  I'm sure it's just a coincidence.  
 
Let me do a couple of announcements at the top and then we'll go to your questions.  
 
The President is looking forward this afternoon to visiting the National Institutes of Health, where he will meet with some of the men and women on the frontlines of the fight against Ebola.  
 
In addition to the news you heard yesterday -- I'm sorry -- that you heard last week about the promising results of NIH’s Ebola vaccine candidate, this morning you saw tangible evidence of just how far we've come in our domestic and international Ebola response over the past few months.  The administration announced today that we now have 35 medical facilities nationwide prepared to treat an Ebola patient.  This is up from three just a couple of months ago.  We've similarly increased the number of domestic labs capable of testing for Ebola from 13 up to 42, just as we've introduced new and enhanced screening and monitoring measures to further protect Americans here at home.
 
Of course, Americans won't be completely safe until we have ended the outbreak in West Africa, which is why we have also focused on stamping out this disease at its source.  We now have some 3,000 American civilian and military personnel on the ground in West Africa, up from several hundred a few months ago.  These brave men and women have been responsible for constructing Ebola treatment units, building a hospital for infected medical workers, training hundreds of health care workers to serve on the frontlines, and countless other response functions.
 
In addition, American leadership has helped to galvanize more than $2 billion in contributions from the international community.  And in Liberia, where our response has been concentrated, we have seen promising results in the form of declining infection rates, indicating that our strategy is working.  
 
And that is precisely why you’ll hear the President make the case today for Congress to swiftly fund the emergency request that the administration submitted last month.  Virtually every initiative underway requires immediate additional funding to be continued or advanced.  The President’s request would provide critical resources to build out our domestic facilities, take the next steps on Ebola vaccines, therapeutics, and diagnostics, fund our vital Ebola response in West Africa, and strengthen global health security to prevent, detect, and rapidly respond to the spread of Ebola in any other vulnerable countries, and to combat similar infectious disease threats.
 
So that is what you have to look forward to today.  I have one other scheduling update, which is that on Friday, the President will meet with newly elected governors from across the country here at the White House to discuss the ways in which the administration can partner with states to promote economic opportunity for middle-class Americans.  The President and the incoming governors will discuss how we can build on our growing economy by creating more jobs and ensuring that every American who works hard has an opportunity to succeed.
 
I understand that the Vice President will be participating in that meeting as well.  The governors who participate, we're talking about the incoming governor of Alaska, Illinois, Maryland, Massachusetts, Pennsylvania, and Texas.  So that will be Friday afternoon.  
 
Q    Just those?
 
MR. EARNEST:  Just those governors, that's correct.
 
Q    What about Arkansas?
 
MR. EARNEST:  Arkansas is not on the list that I have here, but if Governor-elect Hutchinson is able to make the trip we’d certainly find a seat for him at the table.  
 
Nedra, do you want to get us started with questions?
 
Q    Yes, please.  Has the President settled on Ash Carter as the Defense Secretary nominee?
 
MR. EARNEST:  I anticipated that -- (laughter) -- you or one of your colleagues might ask me about this.  What I can tell you is not much.  I don't have any personnel announcements to make today.  But as soon as we're in a position to start making those announcements we'll be sure to let you know.  
 
Mr. Carter is obviously somebody who has generated a lot of headlines today.  He is somebody who has previously served the administration as the Deputy Secretary of Defense, a position that he filled very ably.  He was confirmed by the United States Senate into that position in September of 2011 by unanimous consent.  So this is an indication that he fulfills some of the criteria that we've discussed in the past.  He’s somebody that certainly deserves and has demonstrated strong bipartisan support for his previous service in government.  He is somebody that does have a detailed understanding of the way that the Department of Defense works.
 
And I personally am a pretty strong advocate of people who have previously performed well in deputy roles being promoted to the top job.  (Laughter.)  That's been a recipe for success in filling previous personnel positions.  (Laughter.)
 
But that said, I don't have an update at all on the process.  I think it's for all these reasons that it's been widely reported that Mr. Carter has been on the short list.  But in terms of where things stand in that process, I just don't have any additional information to share at this time.
 
Q    Is anyone else on the short list?  And would you describe him as the leading candidate?  You seem to have a lot of nice things to say about him.
 
MR. EARNEST:  Well, he is somebody who did serve -- has served the President and the American people well previously in this administration.  But I don't have any additional insight to share with you about the process or other people involved in the process, or even any additional information about the timing of that process.
 
Q    But there are reports out there saying that the President has selected him.  Are those reports inaccurate?
 
MR. EARNEST:  I've read those reports, but I can't comment on them at this point.
 
Q    On Ebola, while the White House today is talking a lot about some of the progress that's being made, Doctors Without Borders is out saying that the international response has been slow and uneven.  And they say the international community has come in and built team management structures, but they’re not providing the hands-on medical care that's needed on the ground. Does the President agree that that's a valid concern, and does he think the international community needs to do more to provide hands-on medical care?
 
MR. EARNEST:  I haven't seen the precise statement that you're referring to, but I can say as a general matter that the administration, including the President, does believe that additional efforts are going to be required if we're going to stop this outbreak in its tracks in West Africa.  There are still a lot of people in West Africa who are suffering.  And as long as people are suffering from the Ebola virus, we know that they are at risk of spreading that disease.
 
While we believe, and continue to believe, that the likelihood of a widespread outbreak in the United States remains exceedingly low, that risk is not zero until we have stopped this disease in its tracks in West Africa.  And that is why you're going to hear the President pretty forcefully advocate for additional resources that can advance the efforts that we've already undertaken to try to stamp out this disease in West Africa.
 
Steve.
 
Q    Josh, one of the ideas circulating up on the Hill is to pass a spending bill through September that leaves DHS at current levels as a way of getting at the immigration orders.  Would the President sign legislation like this?
 
MR. EARNEST:  Well, Steve, you're right, that is one of many ideas circulating on Capitol Hill.  I know that's something that Republicans have been talking about in a meeting that they convened on the House side earlier today.  I don't have a specific reaction to that proposal other than to say that the administration believes that it's the responsibility of Congress to pass a full-year budget for the federal government.  And that is what we would like to see them do.
 
We’d like to see them pass that full-year budget for the full government.  That's not -- as I think I said yesterday, we're not asking them to do anything heroic.  We're asking them to do their job.  And that is a responsibility that has been given to the United States Congress by the founders of this country and we believe it's important for the Congress to fulfill that responsibility for a variety of reasons, including that Republicans themselves have observed that adding some consistency and some certainty to this process is good for the economy.  It's good for people who are trying to make business decisions that they know that they don't have to worry about a shutdown of the government or a partial shutdown of the government.  
 
So we're hopeful that Republicans will follow their own advice in that regard and pass a full-year budget for the full federal government.
 
Q    Are you seeing the warning signs of another government shutdown looming in the next few weeks?
 
MR. EARNEST:  Well, there are people who probably do a better job of reading the tea leaves, so to speak, of the Republican conference than I.  But Senator McConnell, as I mentioned yesterday, was pretty declarative shortly after the election that there wouldn't be a shutdown.  He obviously is somebody who is going to have pretty significant say over how this process works.  So we certainly take some heart in Senator McConnell’s comments.  
 
We also take some heart in the view that's been expressed by people in both parties that a government shutdown is not good for the American economy and a government shutdown, at least in the fall of 2013, was not good for the political prospects of Republicans.  I don't think that's everybody’s view, but I think that is -- I feel confident in saying that's the majority view, at least of the majority of Republicans here in Washington.  So I hope that that prevailing view will carry the day this time, too.
 
Michelle.
 
Q    Hearing some of the testimony today for the House Homeland Security Committee that seemed to not bode well for Congress wanting to fund the immigration measure.  I don't know if you read any of that testimony, but it seemed to be some -- at least a strong feeling as we've heard in some of the rhetoric prior.
 
MR. EARNEST:  Well, I did not have a chance to watch that testimony firsthand.  I did read some of the coverage of it this morning.  I was not particularly surprised that people who we’re critical of the President’s announcement a couple of weeks ago reiterated that criticism in the context of Secretary Johnson’s hearing today.  
 
But the fact is Republicans have long adopted the view that is contrary to the view of the vast majority of Americans that we shouldn’t reform our broken immigration system.  They think that's a bad idea.  The President happens to disagree, and that's why the President acted on his own within the confines of his authority to try to reform as much of the broken immigration system as he possibly could.  That's the nature of the step that the President took about 10 days ago; that's what Secretary Johnson discussed on Capitol Hill today.  And I'm not particularly surprised that there were some House Republicans who were critical of that effort.  But, again, those House Republicans who had pretty negative things to say have a view of immigration reform that stands in stark contrast with the view that has been articulated by the President, the view that's been articulated by Senate Democrats, the view that's been articulated by some Senate Republicans, the view that's been articulated by business leaders all across the country, the view that's been articulated by law enforcement officials all across the country, the view that's been articulated by the Catholic bishops and leaders of the evangelical faith community in this country.
 
So the harsh words from House Republicans today may have earned them some ink and maybe even some coverage on cable television today, but it doesn’t change the fact that they, because of their views on this issue, remain pretty isolated from the American public.
 
Q    For two days now we've heard you really kind of stridently push for the funding for Ebola.  Does the administration feel like there’s any confidence in getting that? It just seems like you feel the need to really stress that.
 
MR. EARNEST:  As I described a little bit yesterday, I think we have seen a recognition on the part of Democrats and Republicans on Capitol Hill that providing the necessary resources to deal with the Ebola outbreak and to ensure that we have a high level of readiness here in this country is a legitimate national priority.  And we certainly are pleased that that seems to be a bipartisan view.  
 
At the same time, even when it comes to issues like immigration reform, we've seen other things that people on both sides of the aisle have identified as a legitimate national priority that haven't made progress in the Congress.  So this is an effort to make sure that we are continuing to remind people across the country and Democrats and Republicans in Congress that fully funding these programs that are improving our readiness here in this country and stamping out this Ebola outbreak in West Africa have the resources necessary to succeed.  It's clearly in the best interest of the country and clearly in the best interest of the American people.
 
Q    But it seems like you feel like there’s a chance that that won't happen.  Do you feel like --
 
MR. EARNEST:  There is a chance that won't happen.  It would be a shame if it didn’t happen, particularly because we have seen expressions of support from Democrats and Republicans about how and why this should be a priority.  So we're going to continue to work this, and obviously the President is going to spend some time talking about this at the National Institutes of Health later today.
 
Q    Okay.  And lastly, on Ferguson.  Yesterday, when we did finally get the list of everybody in attendance, I noticed that there weren't any members of the Ferguson Police Department among the law enforcement.  Any particular reason for that, why you wouldn't have included that department in particular?
 
MR. EARNEST:  Well, the President was interested in gathering stakeholders from across the country, not just one community.  So I can't account for sort of who was not a participant in the meeting, but I can tell you those who did participate in the meeting I do think felt like it was a really important discussion, and even debate, in some instances, to have about the importance of building bridges and restoring some trust between law enforcement agencies and the communities that they’re sworn to serve and protect.
 
Q    The administration didn’t feel like it was necessary to put somebody from that police department on there?
 
MR. EARNEST:  No, that this is the kind of discussion that is taking place not just in Ferguson, but in communities all across the country.  And I think the President was able to tap into that broader national sentiment in the context of this meeting even though it didn’t include law enforcement officials from Ferguson, Missouri.
 
Cheryl.
 
Q    Thanks, Josh.  There are a couple of different tax extender proposals on the Hill right now --
 
MR. EARNEST:  At least a couple.
 
Q    At least a couple.  The House is set to vote on a one-year package.  The Senate Democrats are looking at a two-year package.  Where is the White House on this?  Would you support a shorter term, and do you have a preference?
 
MR. EARNEST:  Well, we have been in close touch with Democrats and Republicans in both the House and the Senate to discuss some of these issues.  Obviously last week we made it known to all of you and to all of them that the President took a pretty dim view of proposals that would shower significant tax benefits on well-connected corporations without providing much relief to working people in this country.  
 
The President thinks that an approach like that is both unfair and bad economic policy.  The President believes that the way that we can really strengthen our economy is to make sure that our economy is growing from the middle out, and we do that by investing in middle-class families and those who are trying to get into the middle class.  And that's why we should be focused on policies that do exactly that.
 
Now, there are some policies that would benefit big businesses but in a way that would actually allow those businesses to create jobs and expand economic growth and opportunity in a way that would be good for middle-class families.  So I'm not suggesting that there aren't some things that we can do that would be beneficial to some businesses in this country, but we need to make sure that we're really focused on the interests and concerns of middle-class families.  That’s what’s most important both, again, because it's the most fair way for us to run the business of the American government; it also is the best way for us to strengthen the economy.
 
Q    So would you veto a one-year package if that's what the House --
 
MR. EARNEST:  Well, I didn’t bring my -- I didn’t walk out here today planning to issue any veto threats, so I don't think I'm going to.  But we'll see what happens over the course of the rest of the briefing.  I'm certainly not going to in response to your question.  
 
We are going to evaluate the proposals that are being discussed on Capitol Hill.  We're going to continue to participate in those discussions and we're hopeful that we’ll be able to come up with something that we believe is good for middle-class families.  
 
Doug.  Nice to see you today.
 
Q    Thanks very much.  Wendell is downstairs hacking up his lungs.
 
MR. EARNEST:  I see.  Thank you for sparing us all.  (Laughter.)  
 
Q    You would not appreciate it.  
 
MR. EARNEST:  I hope Wendell gets well soon, though.  
 
Q    The House is expected to vote as early as next week on overturning the President’s executive action on immigration.  If the Senate acts similarly, will the President veto?
 
MR. EARNEST:  Well, we have indicated that the President would strongly oppose any sort of legislative effort to undo the executive action that he announced about 10 days ago.  The actions that the President is taking are well within the confines of the law and within the authority that he’s been given by the United States Constitution.  They also are clearly in the best interest of the American people.  We need to restore some accountability to our immigration system, and that's exactly what the President’s executive proposals would do.  It would streamline our legal immigration system.  It would also do a lot to bring millions of people who are already in this country out of the shadows, make them pay taxes, make them get right with the law.  
 
And the fact is the closest thing we have to amnesty in this country is doing nothing, and that's exactly what House Republicans seem to be advocating.  
 
Q    Another subject, different question.  As you know, this public interest group, this watchdog group, Cause of Action, sued the IRS last September, seeking all documents from the IRS, taxpayer information that may have been shared with the White House or with the executive branch.  A federal judge last September ordered the IRS to turn over those documents by a deadline of yesterday, December 1st.  Instead of turning over the documents, TIGTA sent a letter to this group, Cause of Action, saying in effect that they were not going to turn them over, they were going to withhold them because they’re privileged taxpayer information.  And the letter to Cause of Action read in part:  “All 2,043 pages of documents we have determined to be responsive were collected by the Secretary of the Treasury with respect to the determination of possible liability under Title 26 of the U.S. Code.  These pages consist of return information protected by the U.S. Code.  Because no such exceptions exist here, we're withholding them.”  
 
Has the United States -- has the White House been given privileged taxpayer information by the IRS that should not have been shared?
 
MR. EARNEST:  Doug, I can tell you that I am not familiar with the specific case that you're raising here.  And that's not surprising to me.  There obviously is some distance between the White House and the IRS because it's an independent organization that's responsible for collecting taxes, and it conducts that business outside the realm of any sort of political interference.  And those are rules that we've adhered to pretty closely.  
 
You're also citing a letter that was written by TIGTA, which is the inspector general, who also is somebody who acts independent of the administration.  So I'd refer --
 
Q    -- saying in the letter that the office of the Secretary of the Treasury prevented them from turning over the documents.  
 
MR. EARNEST:  Well, I'd refer you to the Treasury Secretary’s office for the explanation for why that may or may not be the case.  I'm just not familiar with the specifics.
 
Q    You're saying as a rule, the White House has never been offered privileged taxpayer --
 
MR. EARNEST:  I can tell you that as a rule that the Obama administration has been very rigorous in following all of the rules and regulations that govern proper communication between Treasury officials and White House officials and the Internal Revenue Service. 
 
Jon.
 
Q    Josh, I want to ask about something else that happened today in the Senate.  You had some of your ambassadors confirmed after a long process.  One of those, Colleen Bell, confirmed as ambassador to Hungary.  If you can remind me, what are Colleen Bell’s qualifications for ambassador?  Is it that she was a soap opera producer?  Is it that she gave hundreds of thousands of dollars or helped to raise hundreds of thousands of dollars for the Obama reelection campaign?  Why was she chosen?
 
MR. EARNEST:  Jon, I can tell you first that you're right, that the confirmation of these individuals to these important ambassadorial posts is long overdue and we certainly are pleased that the Senate has finally acted on them.  
 
As it relates to Ambassador Bell, she is somebody who retains the confidence -- well, let me say it this way.  Ambassador Bell has the President’s confidence that she will do an excellent job representing the United States and maintaining the important relationship that the United States has with the government and the people of Hungary.
 
     Q    But where does the President get that confidence?  I mean, in her confirmation hearing, she couldn’t even name a single strategic interest the United States had with Hungary.
 
     MR. EARNEST:  Well, she certainly is somebody, again, that has had her own distinguished private sector career.
 
     Q    As a soap opera producer.
 
     MR. EARNEST:  Well, and as somebody who obviously has succeeded in the business world.  And she is somebody that the President has confidence will be able to maintain our relationship with the government and the people of Hungary. 
 
     Q    Can you tell me that the fact that she helped raise hundreds of thousands of dollars for the President’s reelection campaign had nothing to do with her appointment?  You can’t say that, can you?
 
     MR. EARNEST:  I can tell you that that’s not the reason that she was chosen.  I can tell you that the reason that she was chosen -- 
     
     Q    -- a factor in the decision?
 
     MR. EARNEST:  Frankly, I was not part of this decision-making process, but I can tell you that the reason that she was chosen is because the President has complete confidence in her ability to represent the United States in that country.
 
     Q    And what does the President think overall of this practice?  Obviously it didn’t start with him.  There’s a long history of this -- of big donors to political campaigns getting rewards with plum ambassadorial posts.  I mean, isn’t this the kind of practice that when he first came to Washington he came to do away with?
 
     MR. EARNEST:  Well, all I can say, Jon, as a general matter is that these ambassadors who are representing our country overseas have very important responsibilities.  And these are responsibilities that the President, nobody here at the White House takes lightly.  I can tell you that these individuals who have been recently confirmed to their post certainly don’t take those responsibilities lightly either.  And we certainly are looking forward to Ambassador Bell being a -- moving to Hungary and getting down to the important work that she has in front of her.
 
     J.C.
 
     Q    Clearly the President’s long-term professional relationship, including Senate colleague, with Secretary of Defense Hagel was an important factor in his appointing him as Secretary of Defense.  Will this criteria still hold with the President in terms of the next -- whoever the next Secretary of Defense nominee will be -- in terms of the President’s knowledge, the working knowledge of this individual and their long-term relationship, and his confidence in the individual?
 
     MR. EARNEST:  Well, J.C., certainly having a personal relationship with the President like Secretary Hagel does is beneficial to him in the role that he has had for the last two years.  He’s been a part of a lot of very important decisions and he’s had to give some unvarnished advice to the President in some very difficult situations.  
 
And having a personal relationship like that is helpful, but it’s certainly not a requirement, and there are a number of other individuals who have important positions in this government that did not have a previous personal relationship with the President -- they didn’t serve with him in the Senate, for example.  So that is an indication that it certainly is a benefit but it’s not a requirement.  
 
     Jon.
 
     Q    Josh, a couple Hill things.  One on the Defense Secretary appointment -- I know you’re not ready to say who it is, we’ll keep guessing.  But I do want to know -- there have been a lot of complaints from Secretary Panetta, from Secretary Gates, and maybe someday from the next secretary -- also from Secretary Hagel -- about the control from the White House.  Can the next nominee expect less micromanagement as previous Defense Secretaries have felt?
 
     MR. EARNEST:  Well, Jon, I do think that looking back -- I’m certainly not a scholar in this area but I do believe that if you sort of look back at previous administrations that there’s always some natural tension that exists between the Pentagon and the White House.  The President is, after all, the Commander-in-Chief, so he obviously has a significant say over what kinds of things are happening over at the Department of Defense.
 
     That said, I think the President has been proud of the service of the three previous -- or the three gentlemen who have served as the Secretary of Defense in this administration because they have fulfilled a very important responsibility in terms of running a large agency that has a significant impact on the core mission of keeping the American people safe.  So the President is pleased with their work and the President has been proud of their leadership, but I think the kind of tension that you’re describing is not at all unique to this administration.
 
     Q    And Senator McCain has said since we got in here today that he is favorably inclined toward Ash Carter -- didn’t say he’d vote for him.  How does that affect the nomination or the possibility of the nomination?
 
     MR. EARNEST:  Well, I’ll just say as a general matter, when Mr. Carter was nominated to be the Deputy Secretary of Defense, he was confirmed with unanimous consent, which means that there wasn’t a single member of the United States Senate who stood up to object to his nomination so I think that is an indication that he is somebody who has succeeded in the past of winning strong bipartisan support for his leadership and government service, and that certainly is part of the criteria for whoever the next Secretary of Defense will be, but having previously served in government is not a requirement for this job.
 
     Q    And if I can piggyback on Cheryl.  She asked if he would veto a one-year tax extender package.  I want to ask the opposite way.  Would the President sign a short-term extender package that has less of these business extensions in it?
 
     MR. EARNEST:  Well, Jon, we’re going to continue to work with members of Congress to examine what’s exactly included in these proposals.  So in the same way I didn’t promise to veto anything when Cheryl asked, I’m not promising to veto anything when you’re asking either.  But we’ll certainly continue to consult as a part of that process and we’ll see what comes out.
 
     Major.
 
     Q    Josh, just following that line of questioning.  Last week, you were able to articulate objections you had to what was emerging.  There’s a House bill that’s on the website.  It’s going to go to rules.  Do you have objections to that?
 
     MR. EARNEST:  Well, the reason that we were able to express such a clear point of view rather strenuously is that it was the emerging outlines of that deal as it was being reported so clearly violated what the President believes is a core principle of his economic philosophy.
 
     Q    What you’ve seen this week would clearly violate it in the same way?
 
     MR. EARNEST:  Not necessarily.  Again, I don’t want to prejudge the outcome here because this is legislation that, yes, has been posted but it was only posted last night and it’s still being reviewed.  So I’m not in a position to --
 
     Q    No, I understand.  Last week it wasn’t even posted and you were objecting to it.
 
     MR. EARNEST:  Right, again, because it was so clearly objectionable and so clearly a contradiction of this core economic -- 
 
     Q    I'm just trying to find where you guys are.
 
     MR. EARNEST:  Right, and what I can tell you is that I guess maybe you could interpret that because we’re not right out of the box forcefully promising to veto it.  We don’t have as bad a view of it as we did this deal that was being discussed on Capitol Hill last week.  The reason I think for that involves a couple of things.  One is that there’s a significant difference between taking one element of a tax code and extending it for one year, and making it permanent.  And that certainly is a significant factor as we evaluate the proposals that are being generated by both the House and the Senate.  So we’re going to continue to consult with that process and we’ll see where we’re at.
 
     Q    -- favorably inclined?
 
     MR. EARNEST:  I don’t think I would go that far.  I think still reviewing is where I’d put it.
 
     Q    Is the process of choosing a Defense Secretary complete?
 
     MR. EARNEST:  Major, there is a lot of interest in this position, as there should be.  I’m not asking names.  I’m just saying is the process complete?
 
     MR. EARNEST:  I know, and there’s a lot of interest in the process, too.
 
     Q    As you constantly remind us, that that is a prerequisite to the ceremonial announcement and presentation.  I’m just trying to find out -- 
 
     MR. EARNEST:  I’ve been right every time that I said that.  (Laughter.)
 
     Q    If you can tell us if the process itself is complete.
 
     MR. EARNEST:  I don’t have any updates on the process.  So I’m not in a position to give -- 
 
     Q    (Inaudible.)
     
     MR. EARNEST:  Yes, I know.
 
     Q    You can’t say one way or the other?
 
     MR. EARNEST:  I don’t have anything to say about the process itself.  When the President -- I guess the one thing I can say about the process is this:  When the President is ready to announce a decision, we’ll make sure that all of you are there to hear it.
 
     Q    Has he reached a decision?
 
     MR. EARNEST:  Again, that’s part of the process that I’m just not ready to talk about.
 
     Q    Fair enough.  Is the Ebola funding issue of sufficient significance that if it’s not included to the satisfaction of the President, that could jeopardize the entire omnibus being drafted for the remaining one year of the budget cycle?
 
     MR. EARNEST:  That’s a good question.  I will say -- I’ll describe it this way.  Ensuring that we have the necessary resources to meet this important criteria, again, to ensure that we have the proper level of readiness here domestically and that we’re dedicating the necessary resources in West Africa to actually stamp out this outbreak is a top national security priority.  The President has articulated that previously, that continues to be a top national security priority today, even if it is getting a little less media attention than it has over the last several months.
 
     So I’m not prepared to issue a veto threat, but I am prepared to say that as the omnibus works its way through the process, we certainly have been in close touch with members of Congress to make sure that they understand that these resources for combatting Ebola should be included in the omnibus, obviously, and will be something -- will be an element of the omnibus package that we’ll be paying very close attention to.
 
     Q    Hoping you had a productive conversation with Katie before the briefing on the NDAA.  The House has made it clear that it’s going to bring that forward later on this week, looking, hoping that it will be not amended in the Senate.  Is that something you’re inclined to support as drafted?
 
     MR. EARNEST:  I did have the opportunity to talk to Ms. Fallon and a couple members of her staff about this issue this morning.  There are a couple things I can say about it.  This is something that administration officials have been working on for quite some time with their counterparts in Congress, both in the House and the Senate, with Democrats and Republicans.  This has been a genuine bipartisan process.  And that’s the way that this process has worked in the past and we’re pleased to see that that’s the way that it appears to be working again this year.
 
     The nature of these kinds of bipartisan efforts, however, though, is that the legislation is essentially a compromise, which means that neither side gets everything that they want.  And certainly in this instance we do not anticipate that the administration is going to be able to get everything that we would like to see included in this package.  
 
     As of this morning -- at least mid-morning, the details of this legislation had not been posted yet and we have not seen them -- the final details.  We do have some insight about what might be there but I’m going to -- 
 
     Q    Are you encouraged by the direction?
 
     MR. EARNEST:  Yes.  I mean, there -- let me actually just go one step farther to say that there are a couple things that we’re looking at that we anticipate will be positive, and a couple of things that we anticipate either won’t be in there or will be in there in a way that we find disappointing.  When it comes to the positives, we do anticipate -- and we spent a lot of time this summer talking about ensuring that the Department of Defense had Title X authority, that they needed to train and equip Syrian opposition fighters.  That is something that we’ve been working closely with Congress to be sure is included in this specific proposal.  
 
     We’ve also been working with members of Congress to ensure that some of the reforms to fight sexual assault in the military is also included in this proposal.  I believe some progress has been made in that regard as well, and we certainly would welcome that progress.  There are a couple of things in there that we are concerned about.  The first is, as has been the case for the last several years, we do anticipate that there will be additional language in this legislation that will limit the President’s ability to close the prison at Guantanamo Bay.  That is something that we have been, frankly, pretty critical of in the past.  If it’s included in there again, it’s something that we’ll be critical of again because, again, the President believes that -- 
 
     Q    Not sufficiently so to veto it?
 
     MR. EARNEST:  Well, we’re going to evaluate the whole package.  
 
     Q    But in the past, I’m just saying.
 
     MR. EARNEST:  Yes, in the past we have gone ahead and signed legislation that included this language, even though we’ve registered our objections with this language at each turn.  
 
     The one last thing that I’ll say about this is the other thing that we have strongly advocated is the inclusion of some badly needed budgetary reforms at the Pentagon.  These budget reforms have been strongly supported by both the civilian and military leadership of the Pentagon.  And they have made the case that these budget reforms are necessary because it has a critical impact on the ability of our men and women in uniform to do their jobs safely and to keep the American people safe.  
 
     So we have advocated for the inclusion of these reforms.  We have reason to believe that these -- that we may not have gotten nearly as many of these reforms as the administration would have liked.  So we’ll review and see what’s in there.  I understand that they’re still making some tweaks to this legislation even as of this morning so there is a chance that maybe some of these concerns could be resolved.  But somebody did -- I don’t remember who it was -- Jon, I guess maybe it was you who asked about sort of this concern that previous Secretaries of Defense have registered about the administration micromanaging the activities of the Pentagon.  
 
The fact is, you have civilian and military leaders at the Pentagon asking Congress for very specific budgetary reforms that will strengthen national security, but time and time again we’ve seen members of Congress refuse to go along with them.  I don’t know if it gets -- if you could do more to micromanage the Pentagon than to refuse to include the budgetary reforms that our civilian and military leadership believe are critically important to the military being able to do their job.
 
     Q    So there’s more micromanaging from Congress than you exercise here at the White House?
 
     MR. EARNEST:  Well, again, we’ll see what the eventual inclusion is in this legislation but certainly if we believe just as a principle that we should give greater freedom of decision-making to military and civilian leaders at the Pentagon, then I would assume we would see strong bipartisan support for some of the budget reforms that those military and civilian leaders say are so important.
 
     Q    One last thing.  Tuesday, when the President was getting some blowback from the audience in Chicago during his immigration remarks, at one point he said, I just took action to change the law.  Did the President misspeak in a moment of sort of passion to try to calm the crowd, or does he fundamentally -- do you fundamentally believe that he has taken action to change the law?
 
     MR. EARNEST:  I think he was speaking colloquially, that what he has put in place -- 
 
     Q    Meaning?
 
     MR. EARNEST:  Meaning that obviously -- 
 
     Q    (Inaudible.)
 
     MR. EARNEST:  Well, no, meaning that it’s the responsibility of the United States Congress to pass laws and it’s the responsibility of the executive branch to implement and enforce them.  So I guess my point is -- 
 
     Q    -- mean by that when he says I just took action to change the law?
 
     MR. EARNEST:  Well, I think the impact of the law certainly has been changed in terms of the way that it affects millions of people who are in this country, and I think that’s what the President was alluding to.  So if there are people who -- 
 
     Q    He did not literally mean he changed the law?
 
     MR. EARNEST:  Well, again, I think that he was speaking colloquially there -- say that five times fast.  Maybe I’ll stop saying it.  (Laughter.)
 
     Carrie, how are you?
 
     Q    Hi.  Good.  How are you?
 
     MR. EARNEST:  I’m doing great, thank you.  (Laughter.)  
 
     Q    Jeh Johnson this morning spoke up pretty forcefully against the short-term CR for his department, describing how it really tied his hands.  And I’m wondering if the White House holds similarly strong views and does that rise to the level of it being enough to not accept that -- vetoing the whole package because of those concerns that DHS is saying it will have a detrimental effect on Homeland Security. 
 
MR. EARNEST:  Well, certainly this is one of the benefits of Cabinet Secretaries testifying before Congress, is they can make sure the members of Congress are acutely aware of the concerns they may have about steps that Congress may be considering.  But again, there are a wide variety of proposals that are being bandied about by Democrats and Republicans on the Hill.  I know that this is a proposal that many House Republicans are pretty focused on today.  So it is our view that Congress should fulfill their responsibility to pass a full-year budget for the full federal government.  I know there are some proposals that are being considered that would stop short of that, and we’ll consider those proposals if and when they are passed by either the House or Senate, or both.  But we believe that it's important for Congress to fulfill their responsibility to pass a full-year budget for the full federal government.
 
Q    You’re not ruling it in or ruling it out at this point? Because it's not yet clear.
 
MR. EARNEST:  Well, I guess because for two reasons -- one, is because, yes, the details of the proposal that House Republicans are focused on are not entirely clear at this point. They haven’t put something forward.  But also because that’s not the only proposal that’s being discussed on Capitol Hill for making sure that we fund the government by December 11th.  So for those two reasons, I’ll reserve judgment, beyond saying that we do believe that Congress has responsibility to pass a full-year budget for the full federal government.
 
April. 
 
Q    Josh, two subjects, one on Ebola.  Since we have not seen any Ebola cases in this country for a while, any new cases, is this country still not out of the woods, as the President said recently, when it comes to Ebola? 
 
MR. EARNEST:  Is the country still not what?
 
Q    Still not out of the woods.  Remember the President said a couple weeks ago in the Roosevelt Room that we are not out of the woods.  Are we still not out of the woods yet?
 
MR. EARNEST:  Well, I think what the President may have been talking about is a number of people who were on the contact tracing lists of a couple of previous Ebola patients.  So I think he was referring to that specific incident.  As a general matter I can say that the President does continue to believe that the likelihood of a widespread outbreak in the United States remains exceedingly low, but the President and his administration continue to be vigilant to make sure that we are at an appropriate level of readiness in this country to deal with an Ebola patient if one should present himself or herself at a medical facility in this country.  So we’re watching that very carefully.
  
     There obviously are very tight monitoring protocols in place to ensure that individuals who have recently traveled in West Africa and are entering this country are being properly screened both as they enter the country but also for a number of days after they have arrived.  Those protocols are in place, are being closely administered -- carefully administered.  
 
And the President continues to believe that the risk to the American public is not entirely eliminated until we’ve entirely eliminated the Ebola virus from West Africa.  And we are still seeing -- despite the progress that has been made, there’s still too many communities in Africa that are fighting this deadly disease.  And the President wants to make sure that we’re devoting the necessary resources from the United States to combat this outbreak and to try to stop it in its tracks, but were also going to continue to urge the international community to step up and fulfill the responsibility that they have to fight this outbreak as well. 
 
     Again, as long as this outbreak is still underway in West Africa it poses a risk to citizens of countries around the globe, and we’d like to continue to see governments and organizations and citizens from countries around the globe assist in the response of this effort.
 
Q    And my last question, I want to tackle a question that I needed an answer for yesterday and will come at it a different way.  Reverend Al Sharpton said, as it relates to President Obama going to Ferguson -- he told me on the phone last night, he says an invite -- if the President were to go to Ferguson, an invite would need to come from the family and come from the community leaders there.  Is that what you’re waiting for, for the President to go to Ferguson?
 
MR. EARNEST:  No, it's not.  
 
Q    What are you waiting for?
 
MR. EARNEST:  Well, again, the President wants to have a national discussion because there are communities all across the nation who are grappling with some of these issues, who are grappling with the challenge of having effective law enforcement that also has the trust of the community that their sworn to serve and protect.  That is difficult work.  
 
What we do know -- the good news is what we do know is that the more trust that a law enforcement agency has from the community the more effective that law enforcement agency can be in fighting crime.  So building those kinds of relationships and facilitating that kind of transparency and accountability is critically important to the basis work of law enforcement.  Our men and women in law enforcement have very difficult jobs.  These are individuals who walk out the door every morning, kiss their kids goodbye and go to work, knowing that they’re prepared at a moment’s notice to put their life on the line to protect the community.  That’s honorable work.  And that’s work that is worthy of our respect and appreciation.  
 
But we also know that those individuals are going to be more effective in their job if they do have the trust in the community that their serving.  So this is a complicated issue.  This is one that communities across this country have been dealing with for decades.  So it's not something that were going to solve over the course of a few weeks, or not one that we’re going to solve in the context of one specific trip, but rather something that were going to address through a sustained effort and a sustained dialogue.  You heard from the President directly himself yesterday indicate his desire to lead that effort. 
 
Q    When you talk about trust and solutions, are you looking at something that could be a short-term solution, a major short-term solution that could really shake up the system or the structure -- the systemic structure that has been there for so long?  Maybe January, February, or after Holder leaves, or before Holder leaves -- you keep talking about trust and solutions.  What could that be and what could that bring?
 
MR. EARNEST:  I don’t think that there is one solution that’s going to work for every community across the country.  I think what we’re going to need, is were going to need to see a commitment from local leaders and local law enforcement stepping up to the plate and deciding what reforms are going to work best for their agency and work best in their community to try to build this bond of trust that we believe is so critically important to fighting crime.  
 
And this was the nature of the conversation that the President had with law enforcement and civil rights leaders and state and local elected officials over in the EEOB just yesterday.  This is difficult work.  And there are several ways in which the federal government can support those efforts at the local level, whether it's additional training, grants for new technology, including body-worn cameras -- there might be other equipment that could be of assistance in this effort.  There certainly are other resources that can be provided to help implement best practices.  Things that work well in one community could be transferred and implemented in another community to have a positive effect on the relationship between the law enforcement agency and the community they serve.  
 
So there are a lot of ways that the federal government can be helpful in this effort, and the President is interested in mobilizing resources at the federal level to do exactly that.
 
John.
 
Thank you, Josh.  On Sunday, Taiwan had very significant elections in which pro-independence candidates routed the ruling Kuomintang Party.  And the call for independence in Taiwan went up.  China has long said that independence would mean harsh action from them against Taiwan.  Is this something the President is following and -- he talks about hot spots so often -- and is the administration still fully committed to the Taiwan Relations Act to protect the Republic of China on Taiwan?
 
MR. EARNEST:  John, I can tell you that the President has been briefed on the outcome of the elections, but for more details on our policy, let me have one of my colleagues at the National Security Council follow up with you to make sure we get you the right answer to that.  
 
Q    Okay.  The other thing I wanted to ask was, Congressman Dan Mica of Florida rereleased a report he did four years ago when Democrats were in charge in the House about government assets being mismanaged by so many different government agencies, the General Services Administration and eight others.  He recommends selling this to private business to manage some of the government buildings and properties and says he has bipartisan support.  Is this something the administration would embrace -- the selling of federal assets to the private sector?
 
MR. EARNEST:  Well, I know this is something that the Office of Management and Budget has been focused on quite a bit under this President’s leadership, that there has been a concerted effort to reduce costs, to cut red tape, and to deal with surplus federal government assets.  And I know that’s been done to save taxpayers not just hundreds of millions of dollars, but I believe even billions of dollars.  And that’s thanks to the cost-cutting efforts of senior members of the Obama administration.
 
     I haven’t seen Representative Mica’s proposal, but it's certainly something we would take a look at.  
 
Chris. 
 
Q    A couple of quick things.  First, on Ebola.  I just wondered, the fact the President has gone out obviously shows some level of concern.  How concerned is the White House that the money might not come through?  And can you give us a little sense now, because he’s been quite below the radar, although he’s out there now, on Ron Klain’s role, particularly as it relates to talking to members of Congress?  
 
MR. EARNEST:  Well, I can tell you, as I mentioned to Michelle, the administration does believe that the funding for these Ebola priorities should be taken very seriously by members of Congress.  There are early indications --
 
Q    How concerned are you that it might not get done?
 
MR. EARNEST:  Well, there are Democrats and Republicans in Congress who have indicated that they share the administration’s view that these are priorities, that there is a need to redouble our efforts to improve readiness in this country, and a need to redouble our efforts in West Africa to stop that outbreak in its tracks so we can entirely eliminate the Ebola risk to the American people.  
 
These are worthy efforts; the President has called them a top national security priority.  I know there are Democrats and Republicans on Capitol Hill who share that view.  Now, as I also mentioned, just because Democrats and Republicans believe something is a priority doesn’t guarantee it's going to get done in Congress.
  
     And so that’s why you’ve seen this administration continue to forcefully advocate for its passage.  And we are hopeful, as I mentioned earlier, that it will be included in an omnibus proposal that would pass through the Congress before December 11th.  
 
As it relates to Mr. Klain, I know that he’s accompanying the President to the National Institutes of Health today and will be participating in those activities while the President’s there. I don’t know of any specific calls that he himself has had with members of Congress, although I certainly wouldn’t rule it out.
 
Q    Is his role still open-ended?
 
MR. EARNEST:  In terms of, does he plan to leave?  Is that what you’re asking?  Open-ended in terms of time, or open-ended in terms of something else?
 
Q    Open-ended in terms of time. 
 
MR. EARNEST:  I see.  No, I don’t know of any plans that are in place for Mr. Klain to leave.  I know that there’s still a lot of important work to ensure that we are stamping out this Ebola outbreak that remains to be done.  And I am pleased to report that Mr. Klain will be here for the foreseeable future to make progress against that goal. 
Victoria, I’ll give you the last one.  
 
Q    Yes.  Were any U.S. intelligence agencies involved in the reported capture of a wife and son of al-Baghdadi?
 
MR. EARNEST:  I have seen those reports about the Lebanese indicating that they had detained an individual who fits that description.  I don’t have much that I can share with you about this.  I certainly can’t talk about any intelligence agency activities from here.  But I know that the Lebanese government has talked a little bit about what they’ve learned, and so I would refer you to them for that information.  
 
Q    Can you talk about whether the U.S. has been involved in any interrogation of this woman and the possible son of al-Baghdadi?
 
MR. EARNEST:  I’m not in a position to do that, no. 
 
Q    On Ebola, has the President reached out to any lawmakers regarding funding?
 
MR. EARNEST:  I don’t know if there are any presidential conversations to share with you.  I know that there have been 
-– well, actually I take that back.  I know that this is something that they discussed when the President convened that lunch here with the congressional leaders shortly after the election.  This is one of the things that was on the agenda, because, again, the President does believe that this is an important national security priority and the President urged leaders in both parties to be supportive of efforts to dedicate necessary resources to fighting the Ebola outbreak and to improving readiness here in this country.  So this is something that the President has discussed with congressional leaders.
 
Q    Was there any thinking that maybe taking the call public might be counterproductive in the sense that there is a sort of naming and shaming element to it?
 
MR. EARNEST:  No, I don’t think there’s any naming and shaming going on in this instance at least.  This is a situation where we’ve seen a lot of Republicans articulate their support for funding these priorities.  We certainly would welcome that support, and rather than shame them, we would actually compliment them for focusing on important priorities.  
 
There’s important work that needs to get done, though, in making sure that the necessary resources are included in this omnibus proposal and that an omnibus proposal gets through the United States Congress before December 11th.  So there’s important work to be done.  It's important for the American people to recognize that work is still on the to-do list, and we hope that Congress will confront that quickly. 
 
Thanks a lot, everybody.  Have a good afternoon.
 
END            
1:57 P.M. EST
 

The White House

Office of the Press Secretary

Remarks by the President on Research for Potential Ebola Vaccines

National Institutes of Health

Bethesda, Maryland

4:54 P.M. EST

THE PRESIDENT:  Thank you, everybody!  It is good to be back.  Thank you.  Thank you so much.  Everybody, please have a seat.  Thank you.  Well, to Secretary Burwell, to Francis Collins, Tony Fauci, your teams, to all of you, thanks so much for welcoming me here today.  It is wonderful to be back to America’s laboratory, even if I don’t always understand what you’re doing.  (Laughter.)

Last year, I welcomed Francis and some of you to the White House to launch our BRAIN Initiative to unlock the mysteries of the mind and to pursue new cures for disease.  And Francis promoted me at the time to “scientist in chief.”  (Laughter.)  Which made me very proud, although I sort of felt guilty that I hadn’t studied more chemistry.  (Laughter.) 

But the work you do here is remarkable, and I just got a fascinating tour of your vaccine research center.   I have to say, I was very impressed with how you can clone a virus gene into a vaccine vector, then subject it to gel electrophoresis.  (Laughter and applause.)  And then pipet the samples into a 96-well microplate.  (Laughter.)  Run it through the world’s most advanced multiparameter flow cytometer.  (Laughter and applause.)  I mean, it was impressive.  (Laughter.)  I’ve been tinkering around the White House, setting up a similar system.  (Laughter.)  We use it for brewing beer.  (Laughter.)  But it works well for your work also.  (Laughter.)      

Now, the last time I was here at NIH, early in my presidency, I came to announce a historic boost in funding for biomedical research.  Because part of American leadership in the world -- one of the things that has always marked us as exceptional -- is our leadership in science and our leadership in research.  And here at NIH, you have always been at the forefront of groundbreaking innovations.  You’ve helped pioneer new treatments for everything from cancer to heart disease to HIV/AIDS.  And as a consequence, you’ve helped not just Americans but people around the world live longer, fuller lives.  You’ve saved countless lives in every corner of the globe.  And so to Francis and Tony, and all your directors and staff, and the researchers that you fund across the country and around the globe, you deserve great thanks for your leadership, and your service, and your patriotism, and your lifesaving work.

And that brings me back to today.  This past summer, as Ebola spread in West Africa, I told my team that fighting this disease had to be a national security priority, and a priority across agencies and across our government.  I realize that here in the United States, some of the attention has shifted away recently -- that’s sort of how our attention spans work sometimes.  Ebola is not leading the news right now.  But I wanted to come here because, every day, we’re focused on keeping the American people safe.  Every day, the NIH is at the forefront of this mission.  NIH personnel have volunteered and deployed to West Africa.  Some have served in medical labs, testing for Ebola.  Some of your clinicians -- members of the U.S. Public Health Service -- have deployed to care for health care workers who got infected in the line of duty.

When Nina Pham, one of the two Dallas nurses who were infected, needed treatment, Tony and his team stepped up and you were ready.  You manned shifts around the clock, day and night.  You remembered your training.  You displayed great skill and professionalism.  You reminded the world that it is possible to treat Ebola patients effectively and safely without endangering yourselves or others.

And all that has made an enormous difference.  Like a lot of Americans, I know you fell in love with Nina-- she was so sweet and big smile, her optimism, her sense of service, and reminded us -- she reminded us of the incredible sacrifices that our tireless nurses make every day, and we can never thank them enough.  And I know Tony thanks Nina for teaching him how to FaceTime.  (Laughter.)  And after she was released, Ebola-free, I was proud to welcome Nina to the Oval Office and give her a big hug, and she’s now back home in Texas, recovering, getting stronger.  And we remember what she told the world when she was released:  “Throughout this ordeal, I have put my trust in God and my medical team.”  And we thank everyone on her team at the NIH Clinical Center who delivered such remarkable care to Nina.

But the point is, is that the work that you have done has continued even if the cameras have gone elsewhere.  And the urgency remains, because if we are going to actually solve this problem for ourselves, we have to solve it in West Africa as well.  And one of the great virtues of what you’ve done here at NIH is reminded people that science matters and that science works.  It’s not always going to be immediate; sometimes it’s going to be iterative and there are going to be some trials and there are going to be some errors and false starts and blind alleys, but the basic concept of subjecting hypotheses to tests and seeing if they work and being able to document them and replicate them -- the basic concept of science -- and making judgments on the basis of evidence, that’s what’s most needed during difficult, challenging moments like the ones that we had this summer and that we continue to have in West Africa.

Last week, just in time for Thanksgiving, NIH and your partners gave us something new to be thankful for, and that was news of the first successful step -— completion of the Phase 1 clinical trials -- of a potential Ebola vaccine.  And on my tour just now, Doctors Nancy Sullivan and Mario Roederer showed me how they and their teams did it.  And I have to say both Nancy and Mario were really good teachers and were very patient with my rudimentary questions, and the lasers were really cool.  (Laughter and applause.)  No potential Ebola vaccine has ever made it this far.  So this is exciting news.  But it’s also a reminder of the importance of government-funded research and our need to keep investing in basic research.  (Applause.)

Because Nancy, as she was talking about the steps that had been taken, showed me -- this is the kind of mementos scientists keep I guess -- is there was some numbers on a little chart -- (laughter) -- from back in 1999? -- in which she had first done some experiments and trials on the Ebola virus.  So this is the product not just of last year’s work; it’s the product of over a decade of inquiry and work.  And at the time, when -- Nancy was explaining when she first had some breakthroughs in understanding the Ebola virus, nobody really gave a hoot.  Until you do.  And that’s part of how science works -- you make investments and you pursue knowledge for knowledge’s sake, in part because it turns out that knowledge may turn out useful later and you don’t always know when.

Last week’s news is still just a first step.  There are no guarantees.  But Dr. Cliff Lane, who is here, is working with Liberian officials to begin large-scale tests in that country.  And other potential Ebola vaccines are also in the works.  I know that here at NIH you’re also working on potential treatments for Ebola.  As you move ahead on all these fronts, I want you to know you have your President’s full support, and the administration’s full support.

You are a vital part of our fight against Ebola, across our government.  Today, we released an update on our efforts, here in the United States and abroad.  And it shows that, because we’ve stepped up our efforts in recent months, we’re more prepared when it comes to protecting Americans here at home.  We’re screening and monitoring arrivals from the affected countries. We’ve equipped more hospitals with new protective gear and protocols.  We’ve conducted outreach and training of hundreds of thousands of healthcare workers. 

A few months ago, only 13 states could test for Ebola; today 36 states can.   Previously, there were only three facilities in the country deemed capable of treating an Ebola patient, including NIH.  Today, we’re announcing that we now have 35 Treatment Centers designated to care for a patient with Ebola.  So this is important progress.  And we’re going to just keep on at it.  And throughout, we are going to be guided by the science -- not by speculation, not by fear, not by rumor, not by panic -- by science.

Now, part of what the science and epidemiology and experience has taught us -- and I’ve said this all along -- is the best way to fight this disease, to protect Americans, is to stop it at its source.  And that’s why the United States continues to lead the global response in West Africa.  Some 3,000 of our servicemembers and civilians are now on the ground -- manning that air bridge, moving in supplies, building treatment units.  I called some of our troops in West Africa on Thanksgiving to express gratitude and they were inspiring, the can-do spirit that they displayed. 

The new Medical Unit we built in Liberia to treat health workers opened last month and has begun discharging patients Ebola-free.  We’ve ramped up the capacity to train hundreds of new health workers per week.  We’ve helped improve burial practices across Liberia.  And as a consequence, we’ve seen some encouraging news:  A decline in infection rates in Liberia.  And meanwhile, over the last few months, the United States has helped rally the international community.  We’ve mobilized more than $2 billion in commitments to this fight because this has to truly be a global effort.  But that money would not be there had it not been for U.S. leadership.

So our strategy is beginning to show results.  We’re seeing some progress.  But the fight is not even close to being over.  As long as this disease continues to rage in West Africa, we could continue to see isolated cases here in America.  In West Africa, this remains the worst Ebola epidemic in history by a long shot.  And although we’ve made some progress in Liberia, we’ve still got work to do.  We are seeing that we still have a lot of work in Guinea, and it’s actually been getting worse in Sierra Leone despite some good efforts from our British partners.  And this can still spread to other countries, as we’ve seen in Mali.  Every hot-spot is an ember that, if not contained, could become a new fire.  So we cannot let down our guard, even for a minute.  And we can’t just fight this epidemic; we have to extinguish it. 

Much of the progress we’ve made -- and the progress we still need to make -- depends on funding that’s running out.  We can’t beat Ebola without more funding.  This is an expensive enterprise.  And that money is running out.  We cannot beat Ebola without more funding.  If we want other countries to keep stepping up, we will have to continue to lead the way.  And that’s why I’m calling on Congress to approve our emergency funding request to fight this disease before they leave for the holidays.  It’s a good Christmas present to the American people and to the world.  (Applause.)

The funding we’re asking for is needed to keep strengthening our capacity here at home, so we can respond to any future Ebola cases.  The funding allows us to keep making progress in West Africa.  Remember, we have to extinguish this disease -- this is not something that we can just manage with a few cases here and there; we’ve got to stamp it out.  The funding is needed to speed up testing and approval of any promising Ebola vaccines and treatments, including those here at the NIH.  It’s needed to help us partner with other countries to prevent and deal with future outbreaks and threats before they become epidemics. 

This is something I want to just focus on for a second.  Tony and I were fondly reminiscing about SARS and H1N1.  (Laughter.)  That’s what these guys do for fun.  (Laughter.)  And we were lucky with H1N1 -- that it did not prove to be more deadly.  We can’t say we’re lucky with Ebola because obviously it’s having a devastating effect in West Africa but it is not airborne in its transmission. 

There may and likely will come a time in which we have both an airborne disease that is deadly.  And in order for us to deal with that effectively, we have to put in place an infrastructure -- not just here at home, but globally -- that allows us to see it quickly, isolate it quickly, respond to it quickly.  And it also requires us to continue the same path of basic research that is being done here at NIH that Nancy is a great example of.  So that if and when a new strain of flu, like the Spanish flu, crops up five years from now or a decade from now, we’ve made the investment and we’re further along to be able to catch it.  It is a smart investment for us to make.  It’s not just insurance; it is knowing that down the road we’re going to continue to have problems like this -- particularly in a globalized world where you move from one side of the world to the other in a day.

So this is important now, but it’s also important for our future and our children’s future and our grandchildren’s future.  And the last few elections, the American people have sent Washington a pretty clear message:  Find areas where you agree, don’t let the areas where you disagree shut things down, work together and get the job done.

I cannot think of a better example of an area where we should all agree than passing this emergency funding to fight Ebola and to set up some of the public health infrastructure that we need to deal with potential outbreaks in the future.  How do you argue with that?  That is not a partisan issue.  That is a basic, common-sense issue that all Americans can agree on.

Now, I have to say I’ve been very encouraged so far by the bipartisan support in our various visits with members of Congress.  For the most part, people have recognized this is not a Democratic issue or a Republican issue -- it’s about the safety and security of the American people.  So let’s get it done.  This can get caught up in normal politics -- we need to protect the American people and we need to show the world how American leads. 

I have to tell you, I traveled to Asia, we had the G20 Summit -- if America had not led, if I had not been able to go to CDC, make a major announcement about the commitments we were going to make, be able to go to the United Nations and basically call on other countries to step up, and know that we were following through with our own commitments, had we not done that, the world would not have responded in the same way.  American leadership matters every time.  We set the tone and we set the agenda.  

Now, in closing, I want to leave with a story that speaks to what we have to do.  Nancy Writebol, is from Charlotte, North Carolina.  She’s a mom, grandma, wife, also a Christian missionary.  Along with her husband, she went to Liberia.  She was doing God’s work -— caring for Ebola patients.  It’s hard to imagine a greater expression of the Christian ethic.  And she was then infected herself.  So she was brought back to Emory in Atlanta, she received excellent care.  Nancy was released in August.  She is Ebola-free, she continues to recover.  And she said this about how people treat her, even today:  “You have some people that just totally wrap their arms around you, and shake your hand.  And then you have other people that stand 10 feet away.”

Some people wrap their arms around you.  Some people stand 10 feet away.  This disease is not just a test of our health systems; it is a test of our character as a nation.  It asks us who we are as Americans.  When we see a problem in the world -- like thousands of people dying from a disease that we know how to fight -- do we stand 10 feet away, or 10,000 miles away, or do we lead and deploy and go to help?   

And I know what kind of character I want to see in America, and I know the kind of character that’s displayed by people here at NIH and some of your colleagues that are deployed right now in Liberia -- that’s who we are.  We don’t give in to fears.  We are guided by our hopes and we are guided by our reason, and we are guided by our faith, and we’re guided by our confidence that we can ease suffering and make a difference.  And we imagine new treatments and cures, and we discover, and we invent, and we innovate, and we test, and we unlock new possibilities. 

And when we save a life and we help a person heal, we go up to them and we open our arms, and we wrap our arms around them with understanding and love and compassion and reason.  That’s what you do here at NIH.  It’s what we do as Americans.  That’s who we are.  That’s who we’ll always be. 

Thank you very much.  God bless you.  God bless the United States of America.  (Applause.)

END
5:17 P.M. EST

President Obama Speaks on the Fight Against Ebola

December 02, 2014 | 22:19 | Public Domain

On December 2, 2014, President Obama visited the National Institutes of Health (NIH) to discuss the progress we’ve made and the work we still need to do to contain and combat the Ebola outbreak.

Download mp4 (823MB) | mp3 (22MB)

The White House

Office of the Press Secretary

Statement by NSC Spokesperson Bernadette Meehan on Al-Shabaab Attacks in Kenya

The United States strongly condemns yesterday’s attacks in Wajir and Mandera counties in Kenya as well other recent attacks by the terrorist group al-Shabaab targeting innocent civilians.  We extend our deepest condolences to the families and loved ones of the at least 38 individuals killed yesterday.  The United States will continue to support Kenya and our regional partners in combating terrorism and violent extremism and protecting human rights. 

President Obama: Why I Acted on Immigration

Ed. Note: President Obama penned an op-ed explaining his decision to do what he can to fix our broken immigration system. This post originally appeared in Gannett newspapers and websites. You can learn more about the President's new steps here


 

Audience Reacts to President Obama's Immigration Aciton

Audience members react as President Barack Obama delivers remarks on immigration at Del Sol High School in Las Vegas, Nev. November 21, 2014. (Official White House Photo by Pete Souza)

We are a nation of immigrants.

For more than 200 years, that heritage has given America a big advantage over other countries. It has kept us young, dynamic, and entrepreneurial. But today, our immigration system is broken.

When I took office, I committed to fixing our broken immigration system. I began by doing what I could to secure our borders. Today, we have more agents and technology deployed to secure our southern border than at any time in our history. Over the past six years, illegal border crossings have been cut by more than half. Although this summer, there was a brief spike in unaccompanied children being apprehended at our border, the number of such children is now actually lower than it's been in nearly two years. Overall, the number of people trying to cross our border illegally is at its lowest level since the 1970s.

"It's Not Just a Ferguson Problem, It's an American Problem" -- Improving Community Policing

Yesterday, the President announced that he will take a number of steps to strengthen community policing and fortify the trust that must exist between law enforcement officers and the communities they serve. As part of this, he proposed a new three-year, $263 million Community Policing Initiative investment package that will increase use of body worn cameras (BWCs) by law enforcement, expand training for law enforcement agencies (LEAs), add more resources for police department reform, and multiply the number of cities where the Department of Justice (DOJ) facilitates community and local LEA engagement.

The new initiative expands programs within the President’s FY 2015 Budget, and builds on them by adding more resources to help integrate the federal government with state and local LEAs to build and sustain trust between communities and those who serve and protect these communities.

The funding would support the following activities:

New Video Provides a Behind-the-Scenes Look at the First 3D-Printed Presidential Portraits

Something big happened earlier this year at the White House Maker Faire

The very first 3D-printed bust of a sitting U.S. president made its debut.

The bust of President Obama was created by a Smithsonian-led team of 3D-digital-imaging specialists, Autodesk and 3D Systems, in collaboration with the University of Southern California’s Institute for Creative Technologies. It took two different technologically sophisticated 3D documentation processes to generate the data needed to create this portrait.

The White House

Office of the Press Secretary

FACT SHEET: Update on the Ebola Response

Since the diagnosis of the first Ebola patient in the United States, we have achieved tremendous progress across all elements of the Administration’s whole-of-government response. In an update provided to President Obama today, White House Ebola Response Coordinator Ron Klain reported that America is far more prepared to cope with Ebola domestically, and much farther along in our efforts to squelch the virus at the source than we were just two months ago, thanks to the work of more than a dozen federal agencies involved in the Ebola response.

Specifically, the progress we have achieved domestically in the past two months includes:

  • Expanded the network of hospitals prepared to deal with Ebola patients, increasing our capacity from 8 hospital beds at just three facilities to 53 beds at 35 designated Treatment Centers nationwide;
  • Grown our Ebola testing capacity from 13 labs in 13 states as of August to 42 labs in 36 states;
  • Required travelers from one of the four Ebola-affected countries to travel via one of five U.S. airports, where an enhanced screening system has been deployed to identify any potential Ebola cases;
  • Put in place national active monitoring guidance for public health officials to maintain daily contact with passengers arriving from an affected country—with even more rigorous monitoring and controls on travelers in higher risk groups;
  • Completed phase 1 clinical trials of the first vaccine to treat Ebola, clearing the way for large-scale clinical trials in West Africa in the weeks ahead.

During a similar timeframe, we have also made marked strides in our overseas response by: 

  • Scaling-up our deployment with thousands of additional civilian and military personnel in West Africa;
  • Constructing and opening three Ebola Treatment Units (ETU) along with a hospital in Liberia to care for healthcare workers who become ill, which discharged its first two patients Ebola-free in late November;
  • Funding medical teams and non-clinical support operations and ensuring essential PPE supply and in-kind commodity support for a total of 24 ETUs across the region;
  • Putting new teams and facilities in place to allow for the training of hundreds of health care workers per week in Liberia;
  • Galvanizing international support for the response, which has resulted in more than $2 billion in commitments since mid-September. 

Virtually every initiative underway requires immediate, additional funding to be continued or advanced. The President’s Emergency Funding Request of $6.2 billion, now pending before Congress, would provide critical resources to build out our domestic Ebola Treatment Centers and Assessment Hospitals; take the next steps on Ebola vaccines, therapeutics, and diagnostics; fund our vital Ebola response in West Africa; and strengthen Global Health Security to prevent, detect, and rapidly respond to the spread of Ebola in any other vulnerable countries and to combat similar infectious disease threats.

The following Fact Sheets provide additional details on this comprehensive response and the progress it has achieved in recent weeks.  

Domestic Preparedness

Ensuring Hospital and Health System Readiness

We have prioritized domestic preparedness and hospital readiness since the diagnosis of the first Ebola patient in Dallas so that additional cases can be diagnosed and treated promptly, effectively, and safely. Whereas we previously had no formal guidelines in place to judge a hospital’s preparedness vis-à-vis Ebola, we have since September devised and implemented a series of tools to assess and improve facility readiness, allowing us to have confidence in our nationwide ability to respond to additional cases at home.  

Ebola Treatment Centers. State and local public health officials, with technical assistance from the Centers for Disease Control and Prevention (CDC) and the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the Department of Health and Human Services (HHS), and in collaboration with hospital officials, have identified substantially increased capacity to treat Ebola patients. Prior to October, there were three facilities in the United States recognized for their biocontainment capability for treating Ebola and other infectious diseases: Emory University Hospital, University of Nebraska Medical Center, and the National Institutes of Health (NIH) Clinical Center.  Today, HHS is announcing that, working with state officials, we now have a network of 35 Ebola-ready Treatment Centers nationwide with 53 treatment beds available. Additional facilities will be added in the next several weeks to further broaden this geographic reach.

  • Hospitals with Treatment Centers have been designated by state health officials, based on a collaborative decision with local health authorities and the hospital administration, to serve as treatment facilities for Ebola patients. Treatment Centers are staffed, equipped, and have been assessed to have the capability, training, and resources to provide the extensive treatment necessary to care for an Ebola patient.   
  • These Treatment Centers have been assessed by a CDC Rapid Ebola Preparedness (REP) team, a concept created in October that brings together experts in all aspects of Ebola care, including staff training, infection control, and personal protective equipment (PPE) use. Since their inception, CDC REP teams have visited 52 facilities in 15 states and the District of Columbia and continue to work with other facilities on preparedness.
  • Because of this approach, more than 80 percent of travelers returning from West Africa are now within 200 miles of a Treatment Center—and would be transported via ambulance.
  • Assessment Hospitals. CDC and ASPR have also made progress working with state and local public health officials in identifying Ebola Assessment Hospitals, another concept launched within the past 60 days. Assessment Hospitals have been and continue to be identified by state health officials as the point of referral for individuals who have a travel history and symptoms compatible with Ebola.
  • These hospitals have the capability to evaluate and care for those individuals for up to 96 hours, initiate or coordinate Ebola testing and testing for alternative diagnoses, and either rule out Ebola or transfer the individual to an Ebola Treatment Center, as needed.
  • While no states had such plans in September, today the states with the majority of travelers from affected countries have developed strategies to evaluate persons under investigation and to provide care for up to 96 hours while Ebola testing can be arranged.

The following 35 hospitals now have Treatment Centers:

  • Kaiser Oakland Medical Center; Oakland, California
  • Kaiser South Sacramento Medical Center; Sacramento, California
  • University of California Davis Medical Center; Sacramento, California
  • University of California San Francisco Medical Center; San Francisco, California
  • Emory University Hospital; Atlanta, Georgia
  • Ann & Robert H. Lurie Children’s Hospital of Chicago; Chicago, Illinois
  • Northwestern Memorial Hospital; Chicago, Illinois
  • Rush University Medical Center; Chicago, Illinois
  • University of Chicago Medical Center; Chicago, Illinois
  • Johns Hopkins Hospital; Baltimore, Maryland
  • National Institutes of Health; Bethesda, Maryland
  • University of Maryland Medical Center; Baltimore, Maryland
  • Unity Hospital; Fridley, Minnesota
  • Children’s Hospitals and Clinics of Minnesota, St. Paul Campus; St. Paul, Minnesota
  • University of Minnesota Medical Center, West Bank Campus; Minneapolis, Minnesota
  • Mayo Clinic Hospital-Rochester, Saint Marys Campus; Rochester, Minnesota
  • Nebraska Medical Center; Omaha, Nebraska
  • Robert Wood Johnson University Hospital; New Brunswick, New Jersey
  • North Shore LIJ/Glen Cove Hospital; Glen Cove, New York
  • HHC Bellevue Hospital Center; New York City, New York
  • Montefiore Health System; New York City, New York
  • New York-Presbyterian/Allen Hospital; New York City, New York
  • The Mount Sinai Hospital; New York City, New York
  • Hospital of the University of Pennsylvania; Philadelphia, Pennsylvania
  • Children's Hospital of Philadelphia; Philadelphia, Pennsylvania
  • Methodist Hospital System in collaboration with Parkland Hospital System and the University of Texas Southwestern Medical Center; Richardson, Texas
  • University of Texas Medical Branch at Galveston; Galveston, Texas
  • University of Virginia Medical Center; Charlottesville, Virginia
  • Virginia Commonwealth University Medical Center; Richmond, Virginia
  • Children’s National Medical Center; Washington, D.C.
  • George Washington University Hospital; Washington, D.C.
  • Medstar Washington Hospital Center; Washington, D.C.
  • University of Wisconsin Health; Madison, Wisconsin
  • Froedert and the Medical College of Wisconsin; Milwaukee, Wisconsin
  • Children’s Hospital of Wisconsin; Milwaukee, Wisconsin

Outreach and Training. We have in the same period conducted extensive outreach to the health care community, including hospitals, clinicians, healthcare unions, and medical and nursing provider associations, focusing on training and keeping health care workers safe and preparing frontline facilities to diagnose and isolate potential Ebola patients. In recent weeks, HHS and CDC have hosted over 100 conference calls, more than 30 webinars, and multiple live training events on infection control principles and appropriate use of PPE. 

  • Specifically, HHS and CDC have educated more than 150,000 healthcare workers via webinars and over 525,000 healthcare workers via online clinical training resources. This includes regular calls with 10,000 nurses, 20,000 physicians and dentists, and targeted outreach to emergency responders, laboratory workers, waste management workers, hospital executives, and others involved at all levels of the response.
  • In addition, more than 8,000 individuals have received instruction at live training events on infection control and PPE, with an additional 20,000 trained via livestream. 

Additional Resources.  In the past 70 days, CDC has also provided additional resources and guidance to assist with hospital readiness. 

  • CDC has released an algorithm for health care facilities to evaluate returning travelers for Ebola;
  • CDC has provided guidance for hospitals on the safe handling, transport and disposal of waste generated from the care of persons diagnosed with or suspected of having Ebola; and,
  • CDC has issued tightened guidance on infection control and PPE for U.S. health care workers, to ensure there is no ambiguity. 

Ensuring Adequate and Effective PPE. We have worked closely with state and local authorities, as well as with domestic and global manufacturers, to ensure an effective Ebola PPE supply chain. Following the release of the updated PPE guidance by CDC in late October, ASPR and CDC began a dedicated effort to assemble PPE kits to deploy to hospitals to supplement other supply mechanisms. As of late last month, CDC had sufficient PPE to supply 50 days of Ebola patient care in its Strategic National Stockpile (SNS).  

  • PPE kits or specific PPE items can be delivered from the SNS to any hospital in the continental United States in less than 24 hours, and can be delivered in significantly less than 24 hours to hospitals in large cities and population centers.
  • To support optimal hospital preparedness and PPE delivery times, HHS is working with the Health Industry Distributors Association and PPE manufacturers to prioritize and, as needed, redirect PPE supplies should any designated Treatment Center be unable to obtain sufficient supplies from within their hospital network, state and local supply chain. 
  • CDC has partnered with Emory University and the University of Nebraska Medical Center to develop a PPE assessment tool for use by CDC’s REP teams to assist hospitals with estimating the volume of products needed to care for an Ebola patient. The REP teams are now providing direct technical assistance to hospitals, starting with those hospitals near points of entry and those in areas with the largest proportions of returning travelers from the affected countries in West Africa.
  • In collaboration with CDC, OSHA has developed and released a PPE selection matrix to help employers select appropriate PPE for workers who may be exposed to Ebola in the course of their work duties. This matrix will provide guidance to employers to both make sure that employees are safe and that regulatory guidelines are followed.
  • Through its Ebola Grand Challenge for Development, which was launched in October, the U.S. Agency for International Development (USAID) is working closely with the Department of Defense (DOD), CDC, and the White House to rally innovators, scientists, and experts to generate pioneering solutions to improve PPE. USAID is moving rapidly to select and test the best ideas from more than 1,200 submissions with the goal of fielding improved PPE in 2015.

Enhancing Domestic Ebola Testing Laboratories

Just as we have expanded the network of hospitals capable of responding to an Ebola patient, CDC’s Laboratory Response Network (LRN) has grown the network of laboratories able to test a potential Ebola specimen. In order to qualify as an LRN Ebola testing lab, the facility must have the appropriate and functioning biosafety level 3 laboratory, the necessary test reagents, and needed PPE to perform the assay safely. A testing lab demonstrates competency by successful completion of a quality assurance panel. Upon completion and evaluation of the panel, the laboratory is considered approved to test for Ebola using the DOD assay.

  • Prior to the recent outbreak in West Africa, Ebola could only be confirmed at the CDC laboratory in Atlanta. In August 2014, 13 LRN laboratories in 13 states were qualified to test for Ebola. As of December 1, 42 LRN laboratories in 36 states are approved to test for Ebola using a DOD test authorized by the Food and Drug Administration (FDA). This has dramatically decreased turnaround time for Ebola results domestically. 
  • Typically, from receipt of a specimen in the lab, a result is available in 4-6 hours.  When compared to the first Ebola specimen domestically tested at Mt. Sinai in August, which took close to 24 hours to complete, this represents a significant decrease in turn-around time. This significant decrease in turnaround time allows clinicians to make patient-care decisions in a shorter timeframe and protects the American public from unnecessary exposures.
  • Since the authorization of the first test for the detection of Ebola in August, there are now a total of six diagnostic tests, which have been authorized for use by FDA, including two commercial tests which are available for general hospital laboratories. One of these has a turnaround time of less than one hour after receipt of a specimen in the laboratory.

Strengthening Prevention and Detection Measures

Just as we have enhanced our domestic capacity to diagnose and treat Ebola patients effectively and safely, we also have made strides in establishing additional protocols to minimize the risk of imported Ebola cases. The approach we have developed is multilayered and involves overlapping safeguards to mitigate risk.

Passenger Departure and Transit Screening. We have worked with our international partners to increase capacity to identify travelers who may be experiencing symptoms of Ebola or diseases, prevent them from traveling, and refer them for appropriate care as necessary.

  • Since August, CDC personnel have worked with officials of Guinea, Liberia, and Sierra Leone to establish robust exit screening procedures. Based on this screening, travelers with fever or other symptoms that may be suggestive of Ebola are denied boarding and referred to appropriate medical care.  A similar program was put in place by French doctors working in Mali, starting in November.
  • In October, we coordinated with foreign governments to institute temperature checks and questionnaires to identify possible symptoms of or exposure to Ebola for passengers in transit. As a result, all travelers transiting through Belgium, Canada, France, Ghana, Morocco, Nigeria, Senegal, and the UK en route to the United States from Guinea, Liberia, and Sierra Leone are subject to such screening. France, the transit point for the vast majority of travelers from Mali to the United States, started to implement the same screening regimen for travelers from Mali in November.  

Arrival Screening and Monitoring for Early Detection. Pursuant to our layered screening approach, health officials now actively monitor recently-arrived travelers for 21 days since exposure, so that public health officials can rapidly identify a potential case, respond with the medical support the patient needs, and prevent transmission to others in the community.

  • The Department of Homeland Security’s (DHS) Customs and Border Protection (CBP) officers observe all passengers as they arrive in the United States for overt signs of illness, and question travelers, as appropriate, at all U.S. ports of entry. Since early October, CBP personnel have conducted enhanced screening of all passengers arriving in the United States from the Ebola affected countries of Guinea, Liberia, and Sierra Leone to detect signs of illness or potential exposure to Ebola. Specifically, CBP and CDC began administering questionnaires, temperature checks, and additional health evaluation as necessary, to travelers arriving from the Ebola affected countries; in mid-November Mali was added to this screening regime.
  • Since late October, air travelers arriving from these countries are required to arrive to one of five U.S. airports where DHS and CDC conduct joint and enhanced screening. 
  • Since late October, CBP has collected screened travelers’ contact information, which CDC has since passed to state public health departments at their final destination in the United States.
  • Since CDC released guidance on October 27th, State public health officials have actively monitored travelers from West Africa for Ebola symptoms for 21 days after the last possible exposure. Under this protocol, passengers identified by screening whose trips began in one of the West African nations are questioned by public health officials daily to check whether they have experienced fever or other possible symptoms of Ebola, and required to report twice daily temperature checks.
  • Through active monitoring, dozens of people have reported fever or other symptoms to public health officials, who were then able to safely transport and isolate the individual for evaluation.
  • Since late October, individuals deemed to be at elevated risk, including returned health care workers, have been subject to “direct active monitoring.” Under this protocol—in addition to twice daily temperature checks—individuals have direct interaction with a public health official daily so that the public health authorities can generate a holistic picture of the individual’s health and take early action should any worrisome indications emerge.

Reducing the Risk of Ebola’s Maritime Spread. While there have been no cases of Ebola in the maritime sector, the U.S. Government, in coordination with state governments and industry, has developed comprehensive procedures for tracking, screening, prevention, and response to the spread of Ebola via ships calling on the United States.  

  • In October, the Coast Guard developed targeted questions, aligned with CDC guidance and with those currently being utilized at airports and other points of entry, for any vessel that is known to have had a port call in Guinea, Liberia, or Sierra Leone within 21 days before arrival. Additionally, DHS began sharing tracking information with international partners in November to increase capacity to identify vessels that have visited the Ebola-affected region.
  • The Administration released comprehensive guidelines on four separate occasions between September and November that provide specific Ebola preparedness, awareness, and isolation guidance or reporting sick passengers. DHS instituted daily coordination with state and local marine exchanges and port authorities to track and screen arrivals at U.S. ports from Ebola-affected countries. 

Developing Countermeasures to Prevent and Treat Ebola

Over the longer-term, vaccines and therapeutics will be a key tool in our arsenal, and we have significantly ramped up development and clinical trials of vaccine and drug candidates. While no therapeutics or vaccines have yet been certified to be safe and effective for treating or preventing Ebola, HHS, led by efforts at NIH, has made progress in recent weeks and is expediting the human clinical trials of several Ebola vaccine and therapeutic candidates.

Ebola Vaccine Development. We are supporting the development of five Ebola vaccine candidates in various stages of development. Two vaccine candidates—cAd3 and rVSV—have been in Phase 1 human clinical trials; three others are still a few months away from the start of trials. 

  • We achieved a major milestone on November 26th when the initial National Institutes of Health’s (NIH) Phase 1 clinical trial for the cAd3 Ebola vaccine candidate, which was developed by the National Institute of Allergy and Infectious Diseases (NIAID) and GlaxoSmithKline, was completed successfully, with results published in the New England Journal of Medicine. The results indicate that the vaccine candidate is safe and induces an immune response. Additional clinical trials of the vaccine are underway or imminent in Atlanta, Baltimore, the United Kingdom, Switzerland, and Mali, among other sites.
  • Phase 1 clinical trials of a second vaccine, rVSV, are underway at the Walter Reed Army Institute of Research and at NIH, with results expected in December.  Additional Phase 1 studies are underway or planned to begin in the near future at clinical research centers in Switzerland, Germany, Kenya, and Gabon in a WHO-coordinated effort, and in Canada. Merck and NewLink Genetics Corporation are collaborating to research, develop, manufacture, and distribute this investigational rVSV vaccine candidate.
  • West African governments are collaborating with the NIH and CDC to plan large Phase 2/3 studies to evaluate the safety and efficacy of vaccine candidates in the community and in health workers in West Africa. These trials are anticipated to begin in the near future.

NIH, DOD, and HHS’ Biomedical Advanced Research and Development Authority (BARDA) are supporting production of tens of thousands of doses of these vaccines on a pilot scale for planned trials. BARDA with FDA assistance is supporting the rapid scale-up and optimization of vaccine manufacturing for these vaccine candidates to ensure that the capacity exists to produce millions of vaccine doses in a timely way if mass vaccination campaigns are able to occur in 2015 in Africa.

In addition to these vaccine candidates, there are three other candidates supported during early stage development by NIH and DOD that are a few months away from the start of Phase 1 clinical trials. 

Ebola Therapeutics Development. Additionally, the U.S. Government is supporting the development of several investigational candidate therapeutics to treat patients infected with the disease. Some have already been employed in patients in the United States and Africa. 

  • ZMapp: Under contract with DOD’s Defense Threat Reduction Agency (DTRA) and BARDA, ZMapp’s antibodies are produced in specially grown tobacco plants and have only been produced in limited quantities. BARDA is sponsoring the manufacturing of ZMapp for Phase 1-2 clinical studies. ZMapp has shown evidence of antiviral activity in animal models of infection.  Clinical studies are expected to start in early 2015 at NIAID. Other clinical studies are slated to begin in affected African countries in early 2015. This therapeutic candidate has been used under an emergency investigational new drug (eIND) application in Ebola-infected patients in the United States, Africa, and elsewhere. Mapp Biopharmaceutical produces ZMapp.
  • TKM-Ebola: TKM-Ebola has undergone testing in nonhuman primates and showed a significant benefit in terms of survival. This therapeutic candidate has been used under an eIND in some Ebola-infected patients in the United States. Plans for studying this drug in clinical trials are under discussion. TKM-Ebola is produced by the Canadian company Tekmira Inc. under a contract from DTRA.
  • BCX4430: BCX4430 is a small molecule drug with recent NIH support that, in preliminary investigations, has been reported to have some antiviral activity against a range of viruses, including Ebola. NIH and the U.S. Army Medical Research Institute of Infectious Diseases are collaborating to evaluate activity in nonhuman primate models of Ebola virus disease as well as human clinical safety trials. Potential for clinical trials has been under discussion depending on assessment of animal study results.
  • Brincidofovir (CMX001): Brincidofovir, originally supported by BARDA as a potential smallpox drug, was reported in one study to show possible inhibition of Ebola virus replication in infected cells. This therapeutic candidate has been used under an eIND in some Ebola-infected patients in the United States. Potential for clinical trials has been under discussion depending on assessment of animal study results. The drug is under development by Chimerix.
  • Favipiravir (T-705): Favipiravir has been in clinical trials for treatment of influenza but also been reported to show some activity against other viruses, including in Ebola-infected cells. This therapeutic candidate was developed by Toyama and is licensed to Fujifilm and Medivector with support from DTRA.  Potential for clinical trials has been under discussion, and it has reportedly been used in some Ebola-infected patients in Europe.    

A Scaled-Up International Response

Recognizing that the only way to eradicate the threat of Ebola in America is to defeat it on the frontlines, we have significantly ramped up efforts to fight the virus in West Africa since the President announced an international scale-up at the CDC in mid-September. Our international response is civilian-led with leadership from USAID and CDC and important roles from HHS, the State Department, and other agencies, totaling more than 200 civilian responders on the ground. Complementing this civilian cadre is the U.S. military, which since mid-September has brought to bear its unique capabilities and scale; nearly 3,000 service members are now in West Africa, augmenting what was a small force of several hundred less than three months ago. The Department in October reprogrammed $750 million in funding for this deployment and the broader response. 

In Liberia, the country with the highest number of Ebola-related deaths, we have achieved progress against a range of activities in recent weeks working together with the Government of Liberia and partners on the ground.

Isolation and Treatment Facilities. In the past month alone, the U.S. military has completed three ETUs in Liberia, and several more are slated to come online in December. The U.S. military will construct a total of 10 ETUs and USAID-funded partners built an additional four; all are slated to be complete within the next several weeks. The United States is funding medical teams and non-clinical support operations and ensuring essential PPE supply and in-kind commodity support at a total of 20 ETUs. As a result of this support, a total of 24 ETUs providing isolation and care facilities throughout Liberia are expected to be operational by the end of January. 

  • In large part due to the U.S. government’s efforts, the number of ETU beds in Liberia has nearly doubled since September. As of December, there are approximately 800 beds available to Ebola patients in facilities built or supported by the United States, and we expect nearly 2,000 to be online by January 1. 
  • To complement the ETUs, we have also worked with the Government of Liberia and NGO partners since September on a comprehensive Community Care Strategy that brings effective care to hotspots inaccessible to treatment facilities and areas prone to flare-ups. Under this strategy, the United States has established six of the 21 needed Community Care Centers located in 15 priority hotspots, and the establishment of rapid response mechanisms to build county-level case management capacity to respond to outbreaks in remote areas that are inaccessible to treatment facilities.
  • Additionally, we are supporting rapid Ebola laboratory testing through six laboratories, which have helped reduce time required for testing samples from several days to hours. Personnel from the U.S. Naval Medical Research Center operate three of these mobile medical labs, the number of which has more than doubled in the past month and will continue to rise. 

Recruiting and Training Health Care Workers. As we have brought additional infrastructure online in recent weeks, we also have sought to ensure sufficient personnel are available to staff these facilities and provide the highest quality care to patients. We are supporting training for health care workers and foreign medical teams in the United States and in Liberia. Prior to their deployment, more than 200 health care workers have been trained in the United States. As of November, we have the capacity to train 200 health care workers per week in Monrovia alone. 

  • Through the U.S. military, moreover, we have established mobile teams to train up to 100 health care workers per week outside of Monrovia. We had no such capacity prior to last month, and the U.S. military since last month has trained hundreds of such health care workers.  

New Hospital for Infected Health Care Workers. To encourage experienced health care workers from around the globe to join in this effort and help ensure they can get the care they need should they become ill, we now have in place an advanced Ebola treatment facility in Monrovia, which the U.S. military constructed. More than 70 members of HHS’ U.S. Public Health Service Commissioned Corps are now treating health care workers in this facility, the Monrovia Medical Unit (MMU), which opened its doors in early November. The MMU last month achieved a milestone by releasing its first two patients, both of whom are now Ebola-free.

Establishing Effective Incident Management. We have provided technical support to establish a fully functioning national Emergency Operations Center (EOC) and Incident Management System in Liberia, which came online in October. We are now working to support county-level EOCs throughout Liberia.

Increasing Safe Burial. Since September, we have met our target of supporting 65 active safe burial teams across all 15 counties in Liberia—greater than 90 percent of responses to dead body alerts occur within 24 hours. In early September, only 12 U.S.-supported burial teams were operational.

Supporting Infection Control. We are facilitating large-scale infection control in Liberia, including procuring and airlifting 130,000 PPE sets to Liberia and trainings for health care workers in infection control outside established Ebola facilities.

Increasing Outreach and Social Mobilization. Through our partners, more than 1.5 million Liberians receive daily radio Ebola messages, and nearly 100,000 households have been directly reached by mobilization teams to date.  This comprehensive social mobilization coverage has resulted in significant behavior change that has played a large role in bending the curve.

A Regional and Global Approach to Mimic Our Success. The decline in infection rates in Liberia witnessed in recent weeks confirms that we have the right strategy in place. With these signs of progress, however, we must not relent in executing this strategy. We know that small outbreaks can quickly flare up and wipe away months of progress. We are committed to expanding the pace, ingenuity, and scale of our response in Liberia, and across the region, to stem this deadly epidemic and to meet the longer-term recovery and prevention needs in West Africa. As such, we have supported the same approaches in Sierra Leone, Guinea, and Mali. The Senegal-based Intermediate Staging Base, which DOD established in September, has helped to facilitate an approach that reaches beyond Liberia. 

  • In Sierra Leone and Guinea, we are supporting EOC and Incident Management Systems; four ETUs, including two in Sierra Leone and two in Guinea; social mobilization; support to a combined six NGO partners to carry out community outreach activities in Sierra Leone and Guinea; contact tracing; safe burials, including 50 teams across all 14 districts of Sierra Leone; and infection prevention. In Sierra Leone, where the outbreak has intensified, we now have more than 60 U.S. Government personnel deployed. In Mali, meanwhile, we surged personnel and resources there and began applying the same response lens, adapted to the current scale of the outbreak.
  • In order to prevent the further spread of Ebola, we are assisting the 13 most at risk countries in West Africa to strengthen their capacity. To date, the United States has hosted three preparedness workshops for regional stakeholders and has sent rapid response teams to the region to provide hands-on assistance to governments in neighboring countries. CDC is also sending staff to each of these countries to provide technical guidance and leadership to preparedness activities, including contact tracing, specimen transport to laboratories and early alert and rapid response systems.
  • More broadly, we also have strengthened capacity in countries across Africa, Asia, and the Middle East that are not equipped to handle Ebola or other deadly biological threats. In late September, the White House brought together ministers and other senior officials from 43 countries. We are now working with these partners to implement over 100 new, concrete commitments, including standing up emergency operations capacity, strengthening laboratory safety, and improving rapid disease detection and surveillance to end outbreaks before they become epidemics.

Leading and Expanding an International Coalition

The United States has led the international effort to confront Ebola, but, as the President has said, we cannot take on this challenge alone.  U.S. leadership has successfully galvanized others to take part. Since mid-September, when President Obama called on the world to act, other nations, private sector stakeholders, international organizations, and multilateral development banks have come together to pledge more than $2 billion to end the epidemic at its source in West Africa. Other senior U.S. officials—including the National Security Advisor, Secretary of State, Secretary of Health and Human Services, and the Ebola Response Coordinator, among others—have since continued to dialogue with their counterparts to enhance and optimize the international response. Fifteen countries have committed more than $800 million in financial and in-kind assistance following engagement by senior Administration officials. 

Among the contributions announced since mid-September:

  • The European Union, including the European Commission and member states, has collectively committed more than $1.2 billion in financial assistance, $171 million in development and early recovery assistance, and other valuable in-kind assistance, such as health care workers and medical evacuation support.
  • African nations have joined together to commit to contribute 2,000 health care workers through the African Union to the affected countries in West Africa, while African business leaders have pledged $28.5 million in financial assistance.
  • The United Kingdom has committed a $359 million package of direct support to help contain, control, treat and ultimately defeat Ebola in West Africa. This includes a commitment to deliver 700 treatment beds in the coming months to Sierra Leone, helping up to nearly 8,800 patients over a six month period, and supporting the roll out of 200 community care centers.
  • Germany has committed more than a $126 million to the Ebola response effort, and pledged to recruit and train several hundred volunteers.  Additionally, Germany has established of an airlift capability from Dakar to Monrovia, Conakry and Freetown, and committed to providing equipment and operational support to a 100-bed World Health Organization (WHO) ETU in Monrovia.
  • France pledged $124 million to the Ebola response, including $14 million to construct an ETU in Guinea.
  • Japan announced $100 million in assistance on top of about $45 million in assistance previously committed. This aid will help rebuild the health system of the affected countries, in addition to support the treatment of patients currently infected with Ebola. Additionally, the Japanese have announced that they are prepared to send up to 700,000 sets of PPE to Liberia and Sierra Leone.
  • China has announced more than $130 million in assistance, including construction and staffing of a 100-bed Ebola treatment unit in Liberia, $6 million for the UN Ebola Multi-Partner Trust Fund, and another $6 million for the World Food Programme.
  • Canada has committed $20.5 million to support further research and development of Ebola medical countermeasures, namely Canada’s Ebola vaccine and monoclonal antibody treatments. Additionally, Canada is contributing $18.3 million to aid organizations, two mobile labs that provide rapid diagnostic support to help local healthcare workers to quickly diagnose Ebola, and $2.2 million worth of personal protective equipment.
  • The African Development Bank contributed more than $220 million towards strengthening West Africa’s public health systems.
  • The Organization of Islamic Cooperation and the Islamic Development Bank announced a $34 million package to support health programs in the countries affected by Ebola, including $6 million for fighting the disease.
  • The International Monetary Fund (IMF) has approved $130 million in emergency financial assistance to Guinea, Liberia, and Sierra Leone to help respond to the Ebola outbreak. Additionally, the IMF plans to make available a further $300 million to stem the Ebola outbreak and ease pressures on Guinea, Liberia and Sierra Leone, through a combination of concessional loans, debt relief, and grants.
  • The World Bank Group is mobilizing nearly $1 billion in financing for the countries hardest hit by the crisis, including more than $500 million for the emergency response and to help speed up the deployment of foreign health care workers to the countries, and at least $450 million to enable trade, investment and employment in Guinea, Liberia, and Sierra Leone.

Building Trust Between Communities and Local Police

President Obama and Vice President Biden meet with elected officials, community and faith leaders, and law enforcement officials on community policing

President Barack Obama and Vice President Joe Biden meet with elected officials, community and faith leaders, and law enforcement officials to discuss how communities and law enforcement can work together to build trust to strengthen neighborhoods across the country. (Official White House Photo by Lawrence Jackson)

Recent events in Ferguson, Missouri and around the country have grabbed the attention of the nation and the world, and have highlighted the importance of strong, collaborative relationships between local police and the communities that they protect.

Today, the Administration announced new steps we’re taking to strengthen the relationships between law enforcement agencies and the communities they are obligated to protect and serve, including:

  • Advancing the use of body worn cameras and promoting proven community policing initiatives
  • Creating a new task force to promote expansion of the community-oriented policing model, which encourages strong relationships between law enforcement and the communities that they serve as a proven method of fighting crime
  • Reforming how the federal government equips state and local law enforcement – particularly with military-style equipment

Get more details about these new actions below.

Related Topics: Civil Rights, Missouri